Cadence Pharma (CADX) Dec volatility at 63, Feb at 111 into FDA goal date
Tweet Send to a Friend
Cadence Pharmaceuticals (Nasdaq: CADX) closed at $9.12. Cadence Pharmaceuticals announced last week that the FDA has ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
